Jason Fortin

Jason D. Fortin

As a member of Impact Advisors’ Discovery & Development team, Mr. Fortin has over 10 years of experience researching emerging healthcare IT trends and analyzing the impact of regulatory requirements on healthcare strategic planning, operations and
delivery. Mr. Fortin’s areas of expertise include IS strategic planning, payment reform, health information exchange, and business intelligence / data analytics.
 
 
 

Posted April 2019
Fortin

CMS and ONC Proposed Rules on Interoperability, Patient Access, Information Blocking, and EHR Certification

Dan Golder, DDS, MBA, Principal Advisor, and Jason Fortin, Senior Advisor, Impact Advisors.  This session focuses on two proposed rules ...
Read More

This Just in: MIPS Information Blocking – New Attestation Requirements for 2017!

Dan Golder, DDS, MBA, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor Impact Advisors.  This session provides late-breaking ...
Read More

MIPS & MACRA Proposed Rule: What’s Changed for 2018 and Beyond

Dan Golder, DDS, MBA, Principal Advisor, Henry Stokman, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor, Impact Advisors. This session examines ...
Read More

Alternative Payment Models: MACRA, Part III

Dan Golder, DDS, MBA, Principal Advisor, Henry Stokman, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor, Impact Advisors ...
Read More

MIPS Math:  An In-depth Look at the MIPS Scoring Methodology, Part II

Dan Golder, MD, Principal Advisor, Henry Stokman, Principal, Jason Fortin, Senior Advisor, and Larry Katzovitz, Senior Advisor, Impact Advisors. This session ...
Read More

Healthcare Trends 2015: Staying Competitive Amid Rising Pressures

Keith MacDonald, Vice President, and Jason Fortin, Senior Advisor Discovery & Development, Impact Advisors.  Keith and Jason discuss the pressures ...
Read More

Timelines/Nuances of Reporting and Penalties

Laura Kreofsky, PMP, CPHIMS, Principal, and Jason Fortin, Senior Advisor, Impact Advisors. Jason and Laura review key MU Stage 2 ...
Read More

Meaningful Use: Stage 2 and Beyond

Jason Fortin, Director, and Erica Drazen, Managing Director, Global Institute for Emerging Healthcare Practices, CSC. While nothing is final, we ...
Read More

Meaningful Use: What Has Changed Since the Final Rule and the Proposed Requirements for Stage 2?

Erica Drazen, Managing Partner, Emerging Practices, and Jason Fortin, Senior Research Analyst, CSC, discuss what has changed since the Final ...
Read More

Meaningful Use: What has changed since the ‘Final’ Rule?

Erica Drazen Managing Partner, Emerging Practices, and Jason Fortin, Senior Research Analyst, CSC, discuss what has changed since the Final ...
Read More